Nexgel (NXGL) Return on Capital Employed (2019 - 2025)
Nexgel (NXGL) reported Return on Capital Employed of 7.52% for Q4 2025, up 3526.0% on a YoY basis from 0.21% in Q4 2024, and up 81.43% quarter-over-quarter from 40.49% in Q3 2025.
Nexgel (NXGL) Return on Capital Employed (2019 - 2025) Analysis & Trends
Nexgel has reported Return on Capital Employed for 7 years, with the latest figure at 7.52% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 3526.0% year-over-year to 7.52%; the trailing twelve-month figure through Dec 2025 stood at 7.52% (up 3526.0% YoY), and the FY2025 full-year result was 7.83%, up 3660.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 7.52%, up from 40.49% in the prior quarter.
- The five-year high for Return on Capital Employed was 7.52% in Q4 2025, with the low at 183.22% in Q1 2021.
- Historically, Return on Capital Employed has averaged 51.67% across 5 years, with a median of 40.05% in 2025.
- The largest YoY upside for Return on Capital Employed was 21970 bps in 2021 against a maximum downside of 7050 bps in 2021.
- Nexgel's Return on Capital Employed stood at 31.83% in 2021, then fell by 6 bps to 33.69% in 2022, then sank by 39 bps to 46.96% in 2023, then gained by 9 bps to 42.78% in 2024, then soared by 82 bps to 7.52% in 2025.
- The last three Return on Capital Employed figures came in at 7.52% (Q4 2025), 40.49% (Q3 2025), and 39.62% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | -7.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.52% |
| Sep 30, 2025 | -40.49% |
| Jun 30, 2025 | -39.62% |
| Mar 31, 2025 | -42.24% |
| Dec 31, 2024 | -42.78% |
| Sep 30, 2024 | -55.18% |
| Jun 30, 2024 | -50.43% |
| Mar 31, 2024 | -45.06% |
| Dec 31, 2023 | -46.96% |
| Sep 30, 2023 | -35.41% |
| Jun 30, 2023 | -38.14% |
| Mar 31, 2023 | -37.33% |
| Dec 31, 2022 | -33.69% |
| Sep 30, 2022 | -30.33% |
| Jun 30, 2022 | -26.47% |
| Mar 31, 2022 | -20.85% |
| Dec 31, 2021 | -31.83% |
| Sep 30, 2021 | -111.46% |
| Jun 30, 2021 | -114.31% |
| Mar 31, 2021 | -183.22% |